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Summary
Background. A prevalence study aimed to update the epide-
miological scenario of Hospital-Acquired Infections (HAI) was 
performed at the San Martino University Hospital of Genoa, the 
Regional Reference Adult-care Center in Liguria, Italy, with more 
than 1300 beds.
Materials and methods. The investigation was performed in 
all the wards, except the Psychiatric Units, between 19th March 
and 6th April, 2007, using a one-day monitoring system for each 
ward. International standardized criteria and definitions for the 
surveillance of HAI were used for the collection of data, which 
were recorded in specific software for subsequent consolidation, 
analysis and quality control.
Results. The hospital infection control staff actively monitored 
912 inpatients: a total of 84 HAI among 72 patients were diag-
nosed, with an overall prevalence of infections and affected 
cases of 9.2% (95% CI: 7.3-11.1) and 7.9% (95% CI: 6.1-9.7), 
respectively. Urinary Tract Infections (UTI) (30.9%), Respira-
tory Tract Infections (RTI) (28.6%) and Blood Stream Infections 
(BSI) (21.4%) were found to be the most frequent infections. As 
expected, both specific prevalence and localization of HAI var-
ied considerably between wards, with the highest values recorded 
in Intensive Care Units (ICU) and in Functional Rehabilitation 
wards. RTI (26.3%) and BSI (13.2%) were found primarily rep-
resented in ICU, while the highest values of UTI (13.3%) were 
registered in Functional Rehabilitation Units. Enterococcus spp. 
(16.8%), Candida spp. (14%), Pseudomonas spp. (12.2), Staphy-
lococcus aureus (10.7%), Escherichia coli (10.3%) and Coagu-
lase-negative staphylococci (CNS) (9.3%) were the most frequent 
pathogens isolated. The overall rate of administration of antibiot-
ics was 55.3% and penicillin (26.7%), cephalosporins (22.8%) 
and fluoroquinolones (17.9%) were found to be the leading anti-
bacterial administered.
Conclusion. Results of the present study have been, and are cur-
rently, used for orientating surveillance and control hospital 
policies, planning activities according to a rational and evidence-
based approach.
Background
The surveillance and control of Hospital-Acquired In-
fections (HAI) is a public health priority in Western 
Countries, primarily on account of the associated health-
care burden, in terms both of morbidity and mortality 
among affected patients [1], but also considering the 
indirect effects associated with onset of infection, both 
economic and social, such as, prolonged length of hos-
pital stay (LOS), re-admissions or additional care, use 
of expensive therapies with potential occurrence of anti-
biotic resistance and also loss of work and social activi-
ties [2, 3].
Acute-health care settings and large teaching hospitals 
are the elective areas where the majority of invasive and 
innovative medical procedures are routinely performed, 
and where critically ill patients are often hospitalized: 
thus, there is clearly a need to strictly adhere to the exist-
ing recommended policies in the prevention of HAI, par-
ticularly in these well-known high-risk institutions [4]. 
In this respect, active surveillance represents the corner-
stone, universally accepted for achieving optimal con-
trol [5, 6]. Adhering to this aspect of the institutional 
and routine patient care-process is often very difficult, 
particularly when the human and financial resources 
available are limited. This represents another reason for 
planning prevention policies, using an evidence-based 
approach (i.e., starting with correct assessment of the 
frequency of infections, their impact on patient health, 
identification of the main associated risk factors and 
conditions), thus ultimately orientating appropriate and 
corrective interventions [7-9].
During the last two years, substantial efforts have been 
made by the Infection Control Committee of the Liguria 
Region, to improve surveillance and control activities: 
particularly, a regional prevalence survey, monitoring 
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3176 hospitalized patients, was performed, in 2007, 
within the existing public adult and pediatric acute-care 
hospitals, with a reported prevalence of 8.9% cases af-
fected by HAI [10]. Herewith, an in-depth analysis of the 
main results, both clinical and microbiological, emerg-
ing from the reference adult acute-care teaching hospital 
of Liguria, collected as part of the above-mentioned re-
gional study, are fully reported and discussed.
Materials and methods 
The investigation was performed at the San Martino 
University Hospital of Genoa, Italy, between 19th March 
and 6th April, 2007, monitoring all the hospital wards, 
except the Psychiatric Units. The survey, on more than 
1300 beds, using a one-day monitoring system for each 
ward, was coordinated by the Medical Directorate of 
the Hospital, in close collaboration with Hygiene Unit 
and Infectious Diseases Unit of the University of Genoa, 
which were also responsible for the methods used and 
final validation and analysis of data. The study was pos-
sible thanks to an ad hoc and extraordinary setting up of 
a working group comprising 10 survey teams, each of 
which with one medical doctor and one infection con-
trol nurse. All the health-care personnel was well trained 
before starting the investigation, in order not only to use 
international standardized criteria and definitions for 
the surveillance of HAI [11-14], but also to record the 
information collected in the specific software for later 
consolidation, analysis and quality control. In particular, 
HAI was defined as an adverse reaction to the presence 
of an infectious agent(s) or its toxin(s) with no evidence 
that the infection was present, or incubating at the time 
of admission to the acute-care setting [14].
Empirical use of antibiotics was defined as the adminis-
tration of treatment to a patient with signs and symptoms 
of infection, without an identified source or microbio-
logic isolate. Targeted therapy was defined as the ad-
ministration of the antibiotic for an identified isolate. 
Only patients with full-hospitalization were enrolled in 
the surveillance, while those transferred or discharged 
on the day of the analysis were excluded. All anagraph-
ic, anamnestic and clinical data, potentially related to the 
onset of infection, were collected by the investigators; 
medical and nurses’ charts as well as consultations with 
the specialists directly in the wards were also used as a 
source of data. Collection of clinical data, directly by the 
patients, was also performed when feasible. Results of 
culture-tests were also collected from all the clinically 
diagnosed cases, both at the time of the survey in the 
ward and within one month thereafter, these findings be-
ing then used in the final ascertainment of the diagnosis 
of the infection.
As far as concerns data analysis, prevalence was calcu-
lated for HAI (number of infections divided by the to-
tal number of patients in the study population) and for 
cases (number of patients with HAI divided by the total 
number of the study population): crude and specific rates 
were recorded both overall and according not only to the 
localization of the infection but also the ward. Relative 
frequencies of infection according to type were also cal-
culated. 
Descriptive analysis of the study population, including 
demographics and distribution of all clinical informa-
tion concerning infections, together with the calcula-
tion of means, medians and confidence intervals, were 
performed using the Statistical Analysis System (SAS) 
package.
Results 
Overall 912 patients were enrolled in the investigation, 
thus a mean hospital bed-occupation rate of 68.5%. 
Mean age of the population under survey was 64.6 years 
(SD 23.1; range: 0-107), with a female-male ratio of 
~1:1. The mean pre-survey LOS accounted for 16.9 days 
(SD: 27.7; range: 1-400; median: 10.0): in particular the 
mean LOS for patients undergoing surgery (n= 312) was 
6.6 days (SD: 16.0; range: 1-244; median: 2). Overall, 
720 of the 912 inpatients enrolled (78.9%) had at least 
one condition of morbidity at the time of the study, and 
593 patients (65.0%) were exposed to at least one in-
vasive medical device, used for diagnosis or treatment. 
The leading specific medical conditions, and the most 
frequent devices used in the study population are sum-
marized in Table I.
As far as concerns infections, a total of 84 HAI oc-
curred in 72 patients, with relative overall prevalence of 
9.2% and 7.9%: most of the patients presented a single 
localization (90.3%), with only 4 (5.5%) and 3 (4.2%) 
individuals respectively presenting 2 or 3 co-infections. 
The most prevalent HAI resulted Urinary Tract Infec-
tions (UTI), Respiratory Tract Infections (RTI) and 
Tab. I. leading medical conditions and most frequent devices used 
among the study population (n = 912).
Leading medical conditions (n = 1335) Percentage (%)
Cardiovascular diseases 30.3
Cancer 15.5
diabetes 10.1
pulmonary chronic diseases 8.5
Immunosoppresive therapy 6.7
Kidney chronic diseases 5.8
previous infection 5.5
other 17.6
Most frequent devices (n= 1112) Percentage (%)
peripheral venous catheter 37.1
Urinary catheter 26.1
Central venous catheter 15.5
surgical drain 7.7
naso-gastric tube 4.7
endotracheal tube 2.8
tracheal cannula 2.7
other 3.4
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Blood Stream Infections (BSI) with values of 2.9 (95% 
CI = 1.8-4.0), 2.6 (95% CI = 1.6-3.6) and 2.0 (95% 
CI=1.1-2.9), respectively. The relative frequencies of 
the leading infection sites are shown in Figure 1. Briefly, 
UTI and RTI, accounting for 30.9% and 28.6%, respec-
tively, together with BSI (21.4%) were found to be, by 
far, the most predominant localizations in the hospital. 
With regards to BSI, 39% (7/18) of these were catheter-
related bacteremia.
HAI numbers and prevalence, referred to ward, overall and 
according to localization, are outlined in Table II. Preva-
lence of HAI varied considerably between hospital units, 
with values ranging from 0 to 47.4% (95% CI = 31.52-
63.28). As far as concerns crude numbers, most of the 
HAI were recorded in Medical wards (n = 37, 44.0%) and 
in Intensive Care Units (ICU) (n = 18, 21.4%), while the 
highest specific prevalence related to ward was record-
ed in ICU (47.4%, 95% CI = 31.52-63.28) and in Func-
tional-Rehabilitation areas (20%, 95% CI = 8.31-31.69), 
followed by Hemato-Oncology (11.8%, 95% CI = 2.95-
20.65) and Medical wards (8.5%, 95% CI = 5.89-11.12).
Even if numbers are limited when analyzed according to 
ward, a particular distribution of certain types of HAI, 
according to the various specific areas, clearly emerged: 
RTI (26.3%, 95% CI: 12.30-14.30) and BSI (13.2%, 
95% CI: 2.44-23.96) were found to be the most preva-
lent localizations within the Intensive Care setting, while 
the same pattern emerged for UTI both in Functional-
Rehabilitation areas (13.3%, 95% CI: 3.38-23.22) and 
in Medical wards (3.7, 95% CI: 1.93-5.47). A similar 
trend was observed for RTI (7.8%, 95% CI: 0.44-15.16) 
in Hemato-Oncological Units. Interestingly, 33.3% of 
the RTI diagnosed in ICU were Ventilation Associated 
Pneumonia (VAP).
Fig. 1. relative frequency of hospital Acquired Infections (hAI, 
n = 84) according to site.
Tab. II. prevalence of hospital Acquired Infections (hAI), overall and according to site, referred to ward.
UTI RTI BSI SSI* GII Other Sitesa HAI Overall
n
(%, 95% CI)
n
(%, 95% CI)
n
(%, 95% CI)
n
(%, 95% CI)
n
(%, 95% CI)
n
(%, 95% CI)
n
(%, 95% CI)
general medicine 
and specialised medicine 
(n = 437)
16
(3.7, 1.93-5.47)
9
(2.1 , 0.76-3.44)
4
(0.9, 0.01-1.79)
1
(2.6, 0-7.59)
2
(0.5, 0-1.16)
5
(1.1, 0.12-2.08)
37
(8.5, 5.89-11.12)
general surgery 
and other specialised surgery 
(n = 193)
2
(1, 0-2.40)
-
-
5
(2.6, 0.35-4.84)
1
(0.8, 0-2.37)
-
-
1
(0.5, 0-1.50)
9
(4.7, 1.71-7.68)
Intensive care unit 
(n = 38)
1
(2.6, 0-7.66)
10
(26.3, 12.30-40.30)
5
(13.2, 2.44-23.96)
-
-
1
(2.6, 0-7.66)
1
(2.6, 0-7.66)
18
(47.4, 31.52-63.28)
hemato-onchology 
(n = 51)
-
-
4
(7.8, 0.44-15.16)
2
(3.9, 0-9.21)
-
-
-
-
-
-
6
(11.8, 2.95-20.65)
obstetrics-gyneacology 
(n = 29)
-
-
-
-
-
-
-
-
-
-
-
-
0
-
orthopaedics-thraumatology 
(n = 68)
1
(1.5, 0-4.39)
-
-
-
-
1
(1.6, 0-4.79)
-
-
2
(2.9, 0-6.89)
4
(5.9, 0.3-11.5)
otorinolaryngology 
(n = 4)
-
-
-
-
-
-
-
-
-
-
-
-
0
-
oculistics 
(n = 6)
-
-
-
-
-
-
-
-
-
-
1
(16.7, 0-46.54)
1
(16.7, 0-46.54)
Urology 
(n = 36)
-
-
-
-
-
-
-
-
-
-
-
-
0
-
Functional rehabilitation 
(n = 45)
6
(13.3, 3.38-23.22)
1
(2.2, 0-6.49)
2
(4.4, 0-10.39)
-
-
-
-
-
-
9
(20, 8.31-31.69)
neonatology 
(n = 5)
-
-
-
-
-
-
-
-
-
-
-
-
0
-
UtI, urinary tract infections; rtI, respiratory tract infections; BsI, bloodstream infections; ssI, surgical site infections; gII, gastrointestinal infections.
* rates in surgical patients.
a other sites: skin and connective tissue infections, bone and joint infections, central nervous system infections, cardiovascular infections, eye infections, 
  ear infections, infections of the reproductive system, unspecified infections.
UtI, urinary tract infections; rtI, respiratory tract infections; BsI, bloodstream 
infections; ssI, surgical site infections; gII, gastrointestinal infections; others, 
central nervous system infections, cardiovascular infections, eye infections, 
ear infections, infections of the reproductive system, unspecified infections
prevAlenCe oF hospItAl-ACqUIred InFeCtIons
83
The specific prevalence of HAI diagnosed in Surgical Units 
was 4.7% (95% CI = 1.71-7.68): only one case could be at-
tributed to SSI, while more than 50% of these infections 
were BSI (prevalence = 2.6%, 95% CI = 0.35-4.84).
Microbiological identification was available in 70 of the 
84 infections (83.3%), while a total of 107 pathogens 
were isolated. HAI were sustained by a single and by two 
or more pathogens in 38 (54.3%) and 32 cases (45.7%), 
respectively. The most frequently found pathogens, 
overall and according to site of infection, are reported in 
Tables III and IV. The proportion of microbiologically 
confirmed HAI according to site was: 80.8% for UTI, 
62.5% for RTI and 100% for BSI. In 11 UTI (42.3%), 7 
RTI (29.2%) and 7 BSI (38.9%), two or more pathogens 
were isolated. In 7 of 18 BSI (38.9%) (5 Coagulase-neg-
ative staphylococci - CNS, 1 Pseudomonas maltophilia 
Multi Drug Resistant - MDR, and in 1 patient Acineto-
bacter baumanii Extended-Spectrum Beta-Lactamase 
– ESBL, and Klebsiella pneumoniae ESBL) and in 6 of 
24 RTI (25%) (4 Methicillin-resistant Staphylococcus 
aureus - MRSA, 1 Acinetobacter baumanii ESBL and 
1 Pseudomonas aeruginosa MDR) multidrug resistant 
pathogens were involved.
As far as concerns antibiotic use, 504 of the 912 patients 
(55.3%) monitored in the investigation received at least 
one dose during the study period. In particular, 291 pa-
tients (57.7%) received one antibiotic and 213 (42.3%) 
a combination of two or more. The indication for anti-
microbial treatment was empirical therapy, prophylaxis 
and targeted therapy in 40.2%, 27.7% and 19.9%, re-
spectively, while no information was available in the 
remaining prescriptions (12.2%).
The most frequently used antibacterial drugs were peni-
cillin (26.7%), cephalosporins (22.8%), fluoroquinolo-
nes (17.9%) and aminoglycosides (5.3%): in particular, 
penicillin (26.4%), cephalosporins (19.3%) and qui-
nolones (19%) being used primarily for empirical treat-
ment, penicillin (37.4%) and cephalosporins (37.4%) 
for prophylaxis, and quinolones (20.6%) and penicillin 
(15.5%) for targeted therapy.
Discussion
The present results represent an update of the global epi-
demiological scenario of HAI in our Hospital, where the 
last wide survey was performed at the beginning of the 
nineties, with an overall prevalence of HAI of nearly 9% 
having been observed [15, 16].
If, on the one hand, some limits have been reported 
concerning the use of prevalence studies to accurately 
monitor the frequency of HAI, on the other, their rapid-
ity, low cost and acceptable sustainability suggest this 
methodological approach to be a useful tool, and, in 
some instances, the only opportunity, to monitor this se-
rious problem, in an active and systematic way, in large 
hospitals [5, 10, 17]. This is particularly the case in the 
present health-care institutions in which the rates of HAI 
are not routinely calculated, or are simply complitely un-
known. The large number of inpatients monitored, the 
high bed-occupation rate, together with the appropriate 
use of an ad hoc protocol, in accordance with the inter-
national methods, definitions and criteria currently used, 
are all factors that add strength to our study.
In the present study, the prevalence of patients with HAI 
was similar to that reported in the broad survey per-
formed in the Liguria region [10], and was also consist-
ent with data reported by other authors, both in Italy and 
elsewhere in Europe, even in the high range [17-23]. In 
this respect, the decision to (i) cover most of the hospital 
settings, (ii) report all the infection types, and (iii) use 
a period- rather than a point-prevalence methodology 
Tab. III. leading pathogens in hospital Acquired Infections (hAI).
Pathogens isolates (n= 107) Number (%)
enterococcus spp. 18 16.8
Candida spp. (C. albicans) 15 (7) 14 (6.5)
pseudomonas spp. (p. aeruginosa) 13 (9) 12.2 (8.4)
staphylococcus aureus (mrsA) 13 (8) 12.2 (7.5)
escherichia coli 11 10.3
Coagulase-negative staphylococci 10 9.3
Acinetobacter baumanni 6 5.6
Klebsiella spp. 5 4.7
proteus spp. 3 2.8
other 13 12.1
mrsA, methicillin-resistant staphylococcus aureus.
Tab. IV. leading pathogens by site of infection.
Site of infection
(pathogens 
isolated)
Pathogens 
isolated (%)
Pathogens 
isolated (%)
Pathogens 
isolated (%)
Pathogens 
isolated (%)
Pathogens 
isolated (%)
UtI (n = 33) enterococcus spp. (27.3) e. coli (24.2) Candida spp. (9.1) Coagulase-negative 
staphylococci (6.1)
Citrobacter 
Freundii (6.1)
Klebsiella spp. (6.1)
proteus spp. (6.1)
other (15)
rtI (n = 25) pseudomonas spp. (28) s. aureus (24) enterococcus spp. (12) Candida spp. (12) other (24)
BsI (n = 27) Coagulase-negative 
staphylococci (25)
enterococcus spp. 
(14.3)
s. aureus (10.7) pseudomonas spp. 
(10.7)
other (39.3)
UtI, Urinary tract Infections; rtI, respiratory tract Infections; BsI, Blood stream Infections.
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need to be considered. Moreover, an overstimation of 
the true frequency of certain HAI, due to the lack, by 
some investigators, of extensive clinical skills and expe-
rience, particularly required to distinguish contaminants 
from true pathogens, can not be excluded. However, 
it is well known that the frequency of HAI is usually 
higher in teaching, or in large-size, medical centers than 
in conventional or smaller institutions [17, 24-26]. Our 
hospital, as is well known, is the only University and 
reference adult acute-care center in the Liguria region, 
being, with its more than 1300 beds, one of the largest 
in Italy, as far as concerns an inpatient population. All 
these issues need to be taken into consideration when in-
terpreting the results collected, particularly, for bench-
marking purposes. Moreover, the relatively high mean 
age of the study population, together with the fact that 
nearly 80% of the patients enrolled were affected by at 
least one serious condition of co-morbidity, might fur-
ther explain the high rate of HAI observed in the present 
study.
Since with evaluation only of the crude overall rate there 
is the risk of obscuring significant problems related to 
the specific HAI in particular settings [27-29], in this 
study frequencies according to site and speciality were 
also calculated. UTI and RTI were found to be the lead-
ing infections, these results being consistent with those 
published in several prevalence studies performed in 
Western Countries [10, 19, 21, 23-25, 27]. Interestingly, 
the highest specific prevalence of UTI was observed in 
long-term areas, such as Functional-Rehabilitation Units 
and Medical wards, both occupied primarily by elderly 
patients, frequently catheterized: these findings are also 
consistent with data reported in large prevalence inves-
tigations performed in other European Countries and in 
Italy [27, 30].
The low prevalence of HAI in Surgical Units, both over-
all and, in particular, those specific for SSI, could have 
been hardly biased by the shorter LOS following surgical 
interventions at our Hospital, due primarily to financial 
and organizational priorities. This would appear to sug-
gest that a methodological approach other than preva-
lence (i.e., longitudinal studies), necessarily monitoring 
the occurrence of HAI during the post-discharge period, 
should be used for surveillance pourposes, as also indi-
cated by other authors [17, 19, 27, 31-33].
BSI emerged as the third most frequent HAI in our 
Hospital, their prevalence (2.0%) being higher when 
compared both with that of the previously mentioned 
regional investigation in Liguria (1.5%) [10] and with 
the data recorded in other regional studies performed 
in Italy (range = 0.3-1.5) [17, 19, 27]. BSI are severe 
clinical pictures and are associated with high rates of 
mortality, particularly among elderly and critically ill 
patients, frequently institutionalized in high-risk set-
tings [5, 34-36]. Moreover, BSI among immunocom-
promized patients can be sustained by opportunistic 
pathogens, as recently reported in our Hospital dur-
ing an epidemic of Ralstonia pickettii bacteremia in 
patients with hematological malignancies and under-
going allogeneic hematopoietic stem cell transplant 
(HSCT) [37]. Assessment of the occurrence of BSI is 
widely recognised as a hospital indicator of the clinical 
performance: the fact that we found the highest preva-
lence of BSI and RTI in critical settings clearly shows 
that much effort is urgently needed to prevent these 
serious clinical pictures, starting from these high-risk 
areas. In this respect, the significant proportion (more 
than 30%) both of catheter-related bacteremia and 
VAP further highlights the need to review and share 
protocols concerning invasive procedures, in which 
the use of central vascular catheters (CVC) and res-
piratory medical devices are foreseen. The independ-
ent role of these invasive devices, in the risk of oc-
currence of HAI, has been clearly demonstrated in the 
literature [17, 38], also in the risk-assessment analysis 
in the recent investigation performed in our Region on 
a very large sample of the inpatient population [10]. 
Furthermore, greater efforts would appear to be neces-
sary in our Hospital, at an organizational level, in order 
to reduce the LOS, which has also been demonstrated 
as an independent risk factor for all-type HAI occur-
rence [17, 18, 21, 38, 39].
With respect to the pattern of isolated pathogens, some 
considerations need to be made. If, on the one hand, our 
microbiological data are roughly in line with those re-
ported in a large regional prevalence survey performed 
in North Eastern Italy [17], on the other, MRSA, as a pro-
portion of Staphylococcus aureus, and CNS were found 
to be more frequently involved in HAI, in the present 
study, than in other similar large surveys performed dur-
ing the last decade in Italy [19, 27]. Indeed, up to 25% 
of BSI were sustained by CNS, currently recognized as 
the leading pathogens associated with this type of infec-
tion [40, 41]. The emergence of these bacteria, usually 
resistant to multiple antibiotics, has been associated, for 
many years, with the increased use of intravascular de-
vices, particularly CVC [28, 42-44]. Moreover, since a 
substantial prevalence of BSI (38.9%) and RTI (25%) 
sustained by multidrug resistant pathogens was found 
in the present study, all these findings further stress the 
need for prompt and appropriate corrective interven-
tions.
Some final considerations on the use of antibiotics: the 
particularly high rate of administration of antibiotics 
found in the present study population (55.3%) clearly 
highlights the need for physicians to correctly follow 
the existing guidelines and recommendations, also in 
the view of the fact that exposure to antibiotics can 
represent an independent risk factor for HAI [17]: in 
addition to optimizing clinical management, this could 
lead to a reduction in the hospital antibiotic-resistant 
pattern, especially desirable in critical settings, with 
consequent improvements in terms both of quality and 
costs. 
Results of the study provide an update of the epidemio-
logical picture of HAI in our Hospital: even taking into 
the right account the above mentioned limitations, this 
knowledge has been already, and is currently, used as the 
scientific basis to planning and improving surveillance 
and control activities. The effectiveness of the corrective 
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interventions adopted needs to be evaluated in the mid-
term, i.e., by means of repeated prevalence investigations 
or, preferably, through longitudinal studies particularly 
in critical settings, depending on the available resources, 
both financial and in terms of full-time professionals 
within the hospital Infection Control Staff.
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